EGFR and cancer: Specifically, previous studies with engineered bivalent NRG1 that activates the ERBB system by forced ERBB4 homodimerization, reproduced the anti-apoptotic effects of NRG1 in cardiomyocytes, without inducing growth of cancer cells29.